Used in biomedical research to quantify levels of RANKL protein in rat samples, this ELISA kit supports studies on bone metabolism, osteoporosis, and inflammatory diseases. It enables researchers to assess osteoclast formation and activity by measuring RANKL, a key signaling molecule involved in bone resorption. Commonly applied in preclinical studies involving arthritis, periodontal disease, and cancer-related bone loss, the kit provides a reliable tool for evaluating therapeutic interventions targeting the RANKL/RANK/OPG pathway. Its high sensitivity and specificity make it suitable for analyzing serum, plasma, and cell culture supernatants in experimental models.